IFACT: Incidental Findings in Advanced Cancer Therapy

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

February 9, 2023

Study Completion Date

February 9, 2023

Conditions
Breast CancerColorectal CancerBladder CancerLung Cancer
Interventions
BEHAVIORAL

Semi-structured interview

Pts will participate in a 45-60-minute, one-on-one, audio-recorded interview. They will be conducted over the telephone or in person at the MSK Counseling Center. They will be conducted in accordance with a semi-structured interview guide developed by our study team of experts in clinical genetics, health psychology, \& qualitative methodology. Topics to be covered in the interview include: 1) perceived potential benefits \& harms of tumor genomic profiling; 2) interest in \& perceived benefits \& harms of incidental findings arising from tumor genomic profiling; 3) anticipated process \& needs for decision-making about learning incidental findings; 4) interest in learning specific kinds of incidental findings (including those related to treatable diseases, different cancers, non-treatable diseases, \& those that only have meaning for family members); 5) preferences about sharing incidental findings with other people; \& 6) implications of \& concerns about incidental findings for family.

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02217891 - IFACT: Incidental Findings in Advanced Cancer Therapy | Biotech Hunter | Biotech Hunter